Current through Register Vol. 24-24, December 15, 2024
(1) For the purpose of reviewing drug prices
and conducting affordability reviews, the board (as established in chapter
70.405 RCW) and the health care cost transparency board (established in chapter
70.390 RCW) may share data with each other and access all data collected under
RCW 43.71C.020 through 43.71C.080 and any analysis prepared by the
authority.
(2) Advisory group
members may not access or review any confidential information.
(3) The information collected by the board
pursuant to RCW 70.405.040 is not subject to public disclosure under chapter
42.56 RCW.
(4) The authority
provides data only after the data recipient, as defined by this chapter, has
signed a nondisclosure agreement. The authority may prohibit access to or use
of the data by a data recipient who violates the nondisclosure
agreement.
(5) Data recipients must
keep data confidential by:
(a) Accessing,
using, and disclosing information only in accordance with this section and
consistent with applicable statutes, regulations, and policies;
(b) Having a public policy purpose to access
and use the confidential information according to chapter 70.405 RCW;
(c) Protecting all confidential information
against unauthorized use, access, disclosure, or loss by employing reasonable
security measures in alignment with the agency information system security
plan, including physically securing any computers, documents, or other media
containing confidential information and viewing confidential information only
on secure workstations in nonpublic areas;
(d) Destroying all confidential information
according to document retention requirements;
(e) Adhering to the confidentiality
requirements in this section after the data recipient is no longer an
authorized data recipient under chapter 70.405 RCW; and
(f) Acknowledging that the data recipient may
be responsible for liability arising from misuse of the data.
(6) Data recipients must not:
(a) Disclose any confidential information, as
defined by WAC 182-52-0010, or otherwise publicly release the confidential
information;
(b) Use or disclose
any confidential information for any commercial or personal purpose, or any
other purpose that is not authorized in chapter 70.405 RCW;
(c) Attempt to identify people who are the
subject of the confidential information;
(d) Discuss confidential information in
public spaces in a manner in which unauthorized individuals could
overhear;
(e) Discuss confidential
information with unauthorized individuals, including spouses, domestic
partners, family members, or friends;
(f) Have any conflicts of interests under the
Ethics in Public Service Act that would prevent the data recipient from
accessing or using confidential information; and
(g) Share information received according to
this chapter with any person who is not authorized to receive confidential
information as specified by this chapter.
